请输入您要查询的百科知识:

 

词条 Minimum inhibitory concentration
释义

  1. Background

      History    Clinical usage  

  2. Methods

      Broth dilution assay  

  3. See also

  4. References

In microbiology, the minimum inhibitory concentration (MIC) is the lowest concentration of a chemical, usually a drug, which prevents visible growth of bacterium. MIC depends on the microorganism, the affected human being (in vivo only), and the antibiotic itself.[1]

The MIC is determined by preparing solutions of the chemical in vitroat increasing concentrations, incubating the solutions with the separate batches of cultured bacteria, and measuring the results using agar dilution or broth microdilution. Results have been graded into susceptible (often called sensitive), intermediate, or resistant to a particular antimicrobial by using a breakpoint. Breakpoints are agreed upon values, published in guidelines of a reference body, such as the U.S. Clinical and Laboratory Standards Institute (CLSI), the British Society for Antimicrobial Chemotherapy (BSAC) or the European Committee on Antimicrobial Susceptibility Testing (EUCAST).[2] There have been major discrepancies between the breakpoints from various European countries over the years, and between those from the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and the US Clinical and Laboratory Standards Institute (CLSI).

[3]

While MIC is the lowest concentration of an antibacterial agent necessary to inhibit visible growth, minimum bactericidal concentration (MBC) is the minimum concentration of an antibacterial agent that results in bacterial death. The closer the MIC is to the MBC, the more bactericidal the compound.[4]

The first step in drug discovery is often the screening of a library drug candidate for MICs against bacteria of interest.[5] As such, MICs are usually the starting point for larger pre-clinical evaluations of novel antimicrobial agents.[6]

Background

History

After the discovery and commercialization of antibiotics, Alexander Fleming developed the broth dilution technique using the turbidity of the broth for assessment.[7] This is commonly believed to be the conception point of minimum inhibitory concentrations.[8] Later in the 1980s, Clinical and Laboratory Standards Institute has consolidated the methods and standards for MIC determination and clinical usage. Following the discovery of new antibacterials, pathogens and their evolution, the protocols by CLSI are also continually updated to reflect that change.[9] The protocols and parameters set by CLSI are considered to be the "gold standard" in the United States and are used by regulatory authorities, such as the FDA, to make evaluations.[10]

Clinical usage

Nowadays, the MIC is used in antimicrobial susceptibility testing. In clinics, more often than not, exact pathogens cannot be easily determined by symptoms of the patient. Then, even if the pathogen is determined, different serotypes of pathogens, such as Staphylococcus aureus, have varying levels of resistance to antimicrobials. As such, it is difficult to prescribe correct antimicrobials.[11] The MIC is determined in such cases by growing the pathogen isolate from the patient on plate or broth, which is later used in the assay.[12] Thus, knowledge of the MIC will provide a physician valuable information for making a prescription. Accurate and precise usage of antimicrobials is also important in the context of multi-drug resistant bacteria. Microbes such as bacteria have been gaining resistance to antimicrobials they were previously susceptible to.[13] Usage of incompatible or sub-MIC levels of antibicrobials provides the selective pressure that has hastened the evolution of resistance in bacterial pathogens.[14] As such, it is increasingly important to determine the MIC in order to make the best choice in prescribing antimicrobials.

MIC is used clinically over MBC because MIC is more easily determined.[9] Minimum bactericidal concentration (MBC), which is the minimum antibacterial concentration resulting in microbial death, is defined by the inability to re-culture bacteria. In addition, drug effectiveness is generally similar when taken at both MIC and MBC concentrations because the host immune system can expel the pathogen when bacterial proliferation is at a standstill.[15] When the MBC is much higher than the MIC, drug toxicity makes taking the MBC of the drug detrimental to patient. Antimicrobial toxicity can come in many forms, such as immune hypersensitivity and off-target toxicity.[16]

Methods

Broth dilution assay

There are three main reagents necessary to run this assay: the media, an antimicrobial agent, and the microbe being tested. The most commonly used media is cation-adjusted Mueller Hinton Broth, due to its ability to support the growth of most pathogens and its lack of inhibitors towards common antibiotics.[17] Depending on the pathogen and antibiotics being tested, the media can be changed and/or adjusted. The antimicrobial concentration is adjusted into the correct concentration by mixing stock antimicrobial with media. The adjusted antimicrobial is serially diluted into multiple tubes (or wells) to obtain a gradient. The dilution rate can be adjusted depending on the breakpoint and the practitioner's needs. The microbe, or the inoculating agent, must come from the same colony-forming unit, and must be at the correct concentration. This may be adjusted by incubation time and dilution. For verification, the positive control is plated in a hundred fold dilution to count colony forming units. The microbes inoculate the tubes (or plate) and are incubated for 16–20 hours. The MIC is generally determined by turbidity.[17]

See also

  • Kirby–Bauer test

References

1. ^McKinnon, PS and Davis, SL. Pharmokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases. in: VL Yu, G Edwards, PS McKinnon, C Peloquin, G Morse (Eds.) Antimicrobial therapy and vaccines, volume II: antimicrobial agents. ESun Technologies, Pittsburgh, PA; 2005: 5–19
2. ^{{cite journal|last=Andrews|first=J. M.|date=1 July 2001|title=Determination of minimum inhibitory concentrations|journal=Journal of Antimicrobial Chemotherapy|volume=48|issue=suppl 1|pages=5–16|doi=10.1093/jac/48.suppl_1.5|pmid=11420333}}
3. ^Seydina M Diene, Cédric Abat, Jean-Marc Rolain, Didier Raoult. How artificial is the antibiotic resistance definition? Lancet Infectious Diseases, Volume 17, No. 7, p690, July 2017. DOI: https://dx.doi.org/10.1016/S1473-3099(17)30338-9
4. ^{{cite book|url=https://books.google.com/books?id=FfG8AQAAQBAJ&pg=PA696|title=Essentials of Medical Pharmacology|last1=Tripathi|first1=K.D.|date=2013|publisher=Jaypee Brothers Medical Publishers|edition= 7th|location=New Delhi, India|pages=696, 697|isbn=9789350259375}}
5. ^Turnidge JD, Ferraro MJ, Jorgensen JH (2003) Susceptibility Test Methods: General Considerations. In PR Murray, EJ Baron, JH Jorgensen, MA Pfaller, RH Yolken. Manual of Clinical Microbiology. 8th Ed. Washington. American Society of Clinical Microbiology. p 1103 {{ISBN|1-55581-255-4}}
6. ^{{cite journal|last=O'Neill|first=AJ|author2=Chopra, I |title=Preclinical evaluation of novel antibacterial agents by microbiological and molecular techniques.|journal=Expert Opinion on Investigational Drugs|date=August 2004| volume=13| issue=8| pages=1045–63| pmid=15268641|doi=10.1517/13543784.13.8.1045}}
7. ^{{Cite book|title=On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae|last=1881-1955.|first=Fleming, Alexander, Sir|date=1944|publisher=H.K. Lewis|oclc=25424051}}
8. ^{{Cite journal|last=Wheat|first=Philip F.|date=July 2001|title=History and development of antimicrobial susceptibility testing methodology|journal=Journal of Antimicrobial Chemotherapy|volume=48|issue=suppl_1|pages=1–4|doi=10.1093/jac/48.suppl_1.1|issn=1460-2091}}
9. ^{{Cite book|title=Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard|date=2012|publisher=Clinical and Laboratory Standards Institute|others=Cockerill, Franklin R., Clinical and Laboratory Standards Institute.|isbn=978-1562387846|edition= 9th |location=Wayne, Pa|oclc=1016466655}}
10. ^{{Cite book|title=Performance standards for antimicrobial susceptibility testing : twenty-second informational supplement|date=2012|publisher=Clinical and Laboratory Standards Institute|others=Cockerill, F. (Franklin), Clinical and Laboratory Standards Institute.|isbn=978-1562387853|location=Wayne, PA|oclc=795927370}}
11. ^{{Cite journal|last=Cameron|first=D. R.|last2=Howden|first2=B. P.|last3=Peleg|first3=A. Y.|date=2011-08-24|title=The Interface Between Antibiotic Resistance and Virulence in Staphylococcus aureus and Its Impact Upon Clinical Outcomes|journal=Clinical Infectious Diseases|volume=53|issue=6|pages=576–582|doi=10.1093/cid/cir473|pmid=21865195|issn=1058-4838}}
12. ^{{Cite book|title=Antimicrobial susceptibility testing protocols|date=2007|publisher=CRC Press|others=Schwalbe, Richard., Steele-Moore, Lynn., Goodwin, Avery C.|isbn=9781420014495|location=Boca Raton|oclc=666899344}}
13. ^{{Cite book|title=Global antimicrobial resistance surveillance system : manual for early implementation.|others=World Health Organization|isbn=978-9241549400|location=Geneva, Switzerland|oclc=950637154|last1 = Organization|first1 = World Health|date=2015-12-15}}
14. ^{{Cite journal|last=Geisinger|first=Edward|last2=Isberg|first2=Ralph R.|date=2017-02-15|title=Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria|journal=The Journal of Infectious Diseases|language=en|volume=215|issue=suppl_1|pages=S9–S17|doi=10.1093/infdis/jiw402|issn=0022-1899|pmc=5853982|pmid=28375515}}
15. ^{{Cite book|title=Antibiotics simplified|last=author.|first=Gallagher, Jason C.|isbn=9781284111293|oclc=952657550|date = 2016-11-21}}
16. ^{{Cite journal|last=Guengerich|first=F. Peter|date=2011|title=Mechanisms of Drug Toxicity and Relevance to Pharmaceutical Development|journal=Drug Metabolism and Pharmacokinetics|volume=26|issue=1|pages=3–14|issn=1347-4367|pmc=4707670|pmid=20978361|doi=10.2133/dmpk.DMPK-10-RV-062}}
17. ^{{Cite book|title=Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard|date=2015|publisher=Clinical and Laboratory Standards Institute|others=Cockerill, F. (Franklin), Clinical and Laboratory Standards Institute.|isbn=978-1562387839|edition= Tenth |location=Wayne, Pa.|oclc=932608948}}
{{Pharmacology}}{{DEFAULTSORT:Minimum Inhibitory Concentration}}

1 : Microbiology terms

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/9/29 13:26:11